Aberrant expression of tumor suppressor proteins in the Ewing family of tumors

Archives of Pathology and Laboratory Medicine

Volumn 125, Issue 9, 2001, Pages 1207-1212

  Maitra, A ^a   Roberts, H ^a   Weinberg, A G ^a   Geradts, J ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN P14; PROTEIN P16; PROTEIN P21; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CANCER SURVIVAL; CELL CYCLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; EWING SARCOMA; FEMALE; FOLLOW UP; GENE CONTROL; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; NEUROECTODERM TUMOR; PHENOTYPE; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ADOLESCENT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM STAGING; PROGNOSIS; RETINOBLASTOMA PROTEIN; RETROSPECTIVE STUDIES; SARCOMA, EWING'S; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0034841867     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ewing's sarcoma and peripheral primitive neuroectodermal tumors after their genetic union
2. Neuroectodermal differentiation in Ewing's sarcoma family of tumors does not predict tumor behavior
3. The Ewing family of tumors - A sub-group of small-round-cell tumors defined by specific chimeric transcripts
4. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG
5. Detection of the (11;22)(q24; q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction
6. Small round blue cell tumors in bone: Prognostic factors correlated to Ewing's sarcoma and neuroectodermal tumors
7. The Ewing family of tumors and the search for the Achilles' heel
8. Abnormalities in cell cycle control in cancer and their clinical implications
9. The cell cycle and cancer
10. The Pezcoller lecture: Cancer cell cycles revisited
11. WAF1, a potential mediator of p53 tumor suppression
12. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: Correlation with retinoblastoma protein expression
13. Loss of p16INK4a expression correlates with decreased survival in pediatric osteosarcomas
14. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers
15. Prognostic impact of P53 status in Ewing sarcoma
16. Expression of P16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression
17. CDK inhibitors: Positive and negative regulators of G1-phase progression
18. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
19. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
20. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors
21. Prognostic impact of INK4A deletion in Ewing sarcoma
22. Mutational alteration of the p16CDKN2a tumor suppressor gene is infrequent in Ewing's sarcoma
23. Analysis of the p16INK4 and TP53 tumor suppressor genes in bone sarcoma pediatric patients
24. p21 (WAF1/Cip1/Sdi1/Pic1) mRNA is expressed in neuroblastoma cell lines but not in Ewing's sarcoma and primitive neuroectodermal tumor cell lines
25. Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region
26. p21/waf1/cip1 and mdm-2 expression in breast carcinoma patients as related to prognosis
27. Expression of p21 (waf1/cip1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma
28. Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer
29. Rb and p16INK4a expression in resected non-small cell lung tumors
30. G1-S transition defects occur in most breast cancers and predict outcome
31. Hypermethylation of the p16 gene in sporadic T3N0M0 stage colorectal cancers: Association with DNA replication error and shorter survival
32. Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence
33. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
34. Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF
35. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status
36. Wild-type and mutant retinoblastoma protein in paraffin sections
37. Immunohistochemical p16INK4a analysis of archival tumors with deletion, hypermethylation, or mutation of the CDKN2/MTS1 gene: A comparison of four commercial antibodies